Nafsika Karavida Discusses U.S. and EU Approaches to Vaccine Patents and Compulsory Licensing Amid COVID-19

Governments, pharmaceutical companies and medical researchers around the world are racing to produce a vaccine for COVID-19, as well as potential drugs to fight the virus in those who contract it. The numbers show at least 70 reported potential vaccines and 150 other drugs for treatment that are in development...

Read More

New Requirement for Foreign Trademark Applicants, Registrants and Parties to TTAB Proceedings

Earlier this month, the United States Patent and Trademark Office (the “PTO”) quietly announced a new rule pertaining to all trademark applicants, registrants, and parties to trademark proceedings whose permanent legal residence or principal place of business is outside the United States. Commencing as of August 3, 2019, when the...

Read More

SCOTUS Update: First Amendment Protects “F-Word” and Other “Immoral” or “Scandalous” Trademarks

Just prior to adjourning for its summer recess, the United States Supreme Court ruled that First Amendment free speech considerations required the United States Patent and Trademark Office (“PTO”) to register the trademark “FUCT.”  The “FUCT” case is the second in three years contesting federal trademark registration content restrictions. In...

Read More